Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/1630
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Cardinali, Daniel Pedro | es |
dc.contributor.author | Vidal, María Florencia | es |
dc.contributor.author | Vigo, Daniel Eduardo | es |
dc.date.accessioned | 2019-05-02T14:01:11Z | - |
dc.date.available | 2019-05-02T14:01:11Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Cardinali, D. P., Vidal, M. F., Vigo, D. E. Agomelatine : its role in the management of major depressive disorder [en línea]. Clinical medicine insights : psychiatry. 2012, 4. doi:10.4137/CMPsy.S7989. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1630 | es |
dc.identifier.issn | 1179-5573 | - |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/1630 | - |
dc.description.abstract | Abstract: Circadian rhythm abnormalities, as shown by sleep/wake cycle disturbances, constitute one the most prevalent signs of depressive illness; advances or delays in the circadian phase are documented in patients with major depressive disorder (MDD), bipolar disorder, and seasonal affective disorder (SAD). The disturbances in the amplitude and phase of rhythm in melatonin secretion that occur in patients with depression resemble those seen in chronobiological disorders, thus suggesting a link between disturbed melatonin secretion and depressed mood. Based on this, agomelatine, the first MT1/MT2 melatonergic agonist displaying also 5-HT2C serotonergic antagonism, has been introduced as an antidepressant. Agomelatine has been shown to be effective in several animal models of depression and anxiety and it has beneficial effects in patients with MDD, bipolar disorder, or SAD. Among agomelatine’s characteristics are a rapid onset of action and a pronounced effectiveness for correcting circadian rhythm abnormalities and improving the sleep/wake cycle. Agomelatine also improves the 3 functional dimensions of depression—emotional, cognitive, and social—thus aiding in the full recovery of patients to a normal life | es |
dc.format | application/pdf | es |
dc.language | eng | es |
dc.language.iso | eng | es |
dc.publisher | Libertas Academica | es |
dc.rights | Acceso Abierto | es |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | es |
dc.source | Clinical medicine insights : psychiatry. 2012, 4 | es |
dc.subject | TRASTORNOS DE LA CONDUCTA | es |
dc.subject | DEPRESION | es |
dc.subject | AGOMELATINA | es |
dc.subject | RECEPTORES DE MELATONINA | es |
dc.subject | ANTIDEPRESIVOS | es |
dc.subject | ANSIOLITICOS | es |
dc.subject | RECEPTORES | es |
dc.subject | RECEPTORES DE SEROTONINA | es |
dc.title | Agomelatine : its role in the management of major depressive disorder | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.4137/CMPsy.S7989 | - |
uca.path | Facultad de Ciencias Médicas|Departamento de Docencia e Investigación | es |
uca.disciplina | MEDICINA | es |
uca.filename | /home/data-uca-generic/folder_generic/IIBiomedicas/agomelatine-role-management-major/metadata.xml | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Cardinali, Daniel P. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Departamento de Docencia e Investigación; Argentina | es |
uca.affiliation | Fil: Vidal, María Florencia. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Departamento de Docencia e Investigación; Argentina | es |
uca.affiliation | Fil: Vigo, Daniel E. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Departamento de Docencia e Investigación; Argentina | es |
uca.version | publishedVersion | es |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Laboratorio de Cronofisiología | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.orcid | 0000-0002-0813-9088 | - |
crisitem.author.orcid | 0000-0003-2291-245X | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
agomelatine-role-management-major.pdf | 521,5 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
166
comprobado en 23-abr-2024
Descarga(s)
193
comprobado en 23-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons